Financial/Nonfinancial Disclosures The author has reported to CHEST the following: C. J. declares grants to her institution from AstraZeneca and Sanofi; consulting fees from AstraZeneca, GlaxoSmithKline, and Chiesi; payment or honoraria for lectures or educational events from AstraZeneca, GlaxoSmithKline, Sanofi, Novartis, and Chiesi; support for attending meetings and/or travel (only when an invited speaker) from AstraZeneca and GlaxoSmithKline; participation on advisory boards for AstraZeneca, 734 GlaxoSmithKline, Chiesi, Sanofi, and Novartis; and an unpaid leadership or fiduciary role for the Lung Foundation Australia and the Asbestos and Dust Diseases Research Institute. All are outside the scope of the current manuscript.